Brachytherapy Market Research Report Information, By Product (Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others), By Type (High Dose-Rate (HDR) Brachytherapy, Low Dose-Rate (LDR) Brachytherapy), By Technique (Interstitial Brachytherapy, Intracavitary Brachytherapy), By Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032
Market Overview
In 2023, the Brachytherapy Market was estimated to be worth USD 0.98 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 6.84% from USD 1.07 billion in 2024 to USD 1.94 billion by 2032 during the forecast period (2024-2032). The market growth is being driven by the increasing number of product launches and the rising incidences of cancer worldwide.
The Brachytherapy Market is experiencing substantial growth because of the introduction of brachytherapy services, which have expanded the treatment options available to cancer patients. Healthcare facilities attract an increasing number of patients who are seeking effective alternatives to conventional radiation therapy as they broaden their offerings to include this minimally invasive, targeted approach. The capacity of brachytherapy to deliver concentrated doses of radiation directly to tumors while preserving healthy tissue is enhancing patient satisfaction and outcomes.
Furthermore, the adoption of shorter treatment durations and reduced side effects is being encouraged by both patients and healthcare providers. Karnataka Medical College and Research Institute (India) implemented brachytherapy services in September 2024, which represented a substantial development in the treatment of cervical and esophageal malignancies.
Market segment insights
The Brachytherapy Market has been segmented into the following based on product: Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others.
The Market has been segmented into High dose-rate (HDR) brachytherapy and Low dose-rate (LDR) brachytherapy based on type.
The Brachytherapy Market has been segmented into intracavity brachytherapy and interstitial brachytherapy based on technique.
The Market has been segmented into Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others, as indicated by indication.
The Brachytherapy Market has been segmented into Hospitals and Specialty Clinics, Cancer Treatment Centers, and Others based on End User.
Regional Perspectives
The Brachytherapy Market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World, as determined by region. In 2023, the market share that North America possessed was the most significant. Nevertheless, the Asia-Pacific region is expected to experience the most significant compound annual growth rate (CAGR) of 7.98% during the forecast period.
The brachytherapy market in North America is undergoing a rapid transformation, which is indicative of the substantial progress made in cancer treatment methods. The demand for effective therapies has increased as cancer rates continue to rise, particularly for localized forms such as prostate, breast, and cervical malignancies.
Several interrelated factors are driving the robust growth of the Asia-Pacific brachytherapy market. The demand for effective treatment options has been significantly increased by the significant increase in the incidence of cancer, particularly breast, prostate, and cervical malignancies.
Additionally, the remainder of the globe is further divided into South America and the Middle East and Africa. The region's economic development has resulted in a rise in healthcare expenditure, which has facilitated the availability of more advanced cancer treatment options.
Major Players
Elekta, Siemens Healthineers AG, BEBIG Medical Gmbh, Becton, Dickinson and Company (US), GE Healthcare (US), Merit Medical Systems (US), Best Medical International, Inc. (US), IsoAid, LLC (US), Theragenics Corporation, Eckert & Ziegler, and other prominent players are among the major participants in the Brachytherapy Market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 PROSTATE CANCER INCIDENCE, BY COUNTRY, 2022
TABLE 3 BREAST CANCER INCIDENCE, BY COUNTRY, 2022
TABLE 4 CERVICAL CANCER INCIDENCE, BY COUNTRY, 2022
TABLE 5 COST OF THE BRACHYTHERAPY BASED ON THE TYPE OF CANCER / CONDITIONS IN VARIOUS COUNTRIES (IN USD)
TABLE 6 GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 7 GLOBAL BRACHYTHERAPY MARKET, FOR AFTERLOADERS & APPLICATORS, BY REGION, 2019–2032 (USD BILLION)
TABLE 8 GLOBAL BRACHYTHERAPY MARKET, FOR RADIOACTIVE SEEDS, BY REGION, 2019–2032 (USD BILLION)
TABLE 9 GLOBAL BRACHYTHERAPY MARKET, FOR ELECTRONIC BRACHYTHERAPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 10 GLOBAL BRACHYTHERAPY MARKET, FOR IMAGING SYSTEMS, BY REGION, 2019–2032 (USD BILLION)
TABLE 11 GLOBAL BRACHYTHERAPY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 12 GLOBAL BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 13 GLOBAL BRACHYTHERAPY MARKET, FOR HIGH DOSE-RATE (HDR) BRACHYTHERAPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 14 GLOBAL BRACHYTHERAPY MARKET, FOR LOW DOSE-RATE (LDR) BRACHYTHERAPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 15 GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 16 GLOBAL BRACHYTHERAPY MARKET, FOR INTERSTITIAL BRACHYTHERAPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 17 GLOBAL BRACHYTHERAPY MARKET, FOR INTRACAVITARY BRACHYTHERAPY, BY REGION, 2019–2032 (USD BILLION)
TABLE 18 GLOBAL BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 19 GLOBAL BRACHYTHERAPY MARKET, FOR PROSTRATE CANCER, BY REGION, 2019–2032 (USD BILLION)
TABLE 20 GLOBAL BRACHYTHERAPY MARKET, FOR BREAST CANCER, BY REGION, 2019–2032 (USD BILLION)
TABLE 21 GLOBAL BRACHYTHERAPY MARKET, FOR CERVICAL CANCER, BY REGION, 2019–2032 (USD BILLION)
TABLE 22 GLOBAL BRACHYTHERAPY MARKET, FOR SKIN CANCER, BY REGION, 2019–2032 (USD BILLION)
TABLE 23 GLOBAL BRACHYTHERAPY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 24 GLOBAL BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 25 GLOBAL BRACHYTHERAPY MARKET, FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019–2032 (USD BILLION)
TABLE 26 GLOBAL BRACHYTHERAPY MARKET, FOR CANCER TREATMENT CENTERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 27 GLOBAL BRACHYTHERAPY MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION)
TABLE 28 GLOBAL BRACHYTHERAPY MARKET, BY REGION, 2019–2032 (USD BILLION)
TABLE 29 NORTH AMERICA BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 30 NORTH AMERICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 31 NORTH AMERICA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 32 NORTH AMERICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 33 NORTH AMERICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 34 NORTH AMERICA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 35 US: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 36 US: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 37 US: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 38 US: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 39 US: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 40 CANADA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 41 CANADA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 42 CANADA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 43 CANADA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 44 CANADA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 45 MEXICO: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 46 MEXICO: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 47 MEXICO: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 48 MEXICO: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 49 MEXICO: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 50 EUROPE BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 51 EUROPE: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 52 EUROPE: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 53 EUROPE: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 54 EUROPE: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 55 EUROPE: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 56 GERMANY: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 57 GERMANY: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 58 GERMANY: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 59 GERMANY: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 60 GERMANY: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 61 FRANCE: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 62 FRANCE: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 63 FRANCE: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 64 FRANCE: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 65 FRANCE: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 66 UK: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 67 UK: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 68 UK: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 69 UK: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 70 UK: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 71 ITALY: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 72 ITALY: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 73 ITALY: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 74 ITALY: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 75 ITALY: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 76 SPAIN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 77 SPAIN: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 78 SPAIN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 79 SPAIN: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 80 SPAIN: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 81 REST OF EUROPE: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 82 REST OF EUROPE: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 83 REST OF EUROPE: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 84 REST OF EUROPE: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 85 REST OF EUROPE: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 86 ASIA-PACIFIC BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 87 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 88 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 89 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 90 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 91 ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 92 CHINA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 93 CHINA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 94 CHINA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 95 CHINA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 96 CHINA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 97 INDIA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 98 INDIA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 99 INDIA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 100 INDIA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 101 INDIA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 102 JAPAN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 103 JAPAN: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 104 JAPAN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 105 JAPAN: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 106 JAPAN: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 107 SOUTH KOREA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 108 SOUTH KOREA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 109 SOUTH KOREA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 110 SOUTH KOREA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 111 SOUTH KOREA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 112 AUSTRALIA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 113 AUSTRALIA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 114 AUSTRALIA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 115 AUSTRALIA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 116 AUSTRALIA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 117 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 118 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 119 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 120 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 121 REST OF ASIA-PACIFIC: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 122 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 123 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 124 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 125 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 126 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 127 REST OF THE WORLD: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 128 MIDDLE EAST: BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 129 MIDDLE EAST: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 130 MIDDLE EAST: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 131 MIDDLE EAST: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 132 MIDDLE EAST: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 133 MIDDLE EAST: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 134 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 135 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 136 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 137 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 138 SAUDI ARABIA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 139 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 140 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 141 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 142 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 143 UNITED ARAB EMIRATES: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 144 OMAN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 145 OMAN: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 146 OMAN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 147 OMAN: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 148 OMAN: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 149 QATAR: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 150 QATAR: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 151 QATAR: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 152 QATAR: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 153 QATAR: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 154 TURKEY: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 155 TURKEY: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 156 TURKEY: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 157 TURKEY: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 158 TURKEY: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 159 KUWAIT: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 160 KUWAIT: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 161 KUWAIT: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 162 KUWAIT: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 163 KUWAIT: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 164 BAHRAIN: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 165 BAHRAIN: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 166 BAHRAIN: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 167 BAHRAIN: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 168 BAHRAIN: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 169 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 170 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 171 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 172 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 173 REST OF MIDDLE EAST: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 174 AFRICA: BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 175 AFRICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 176 AFRICA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 177 AFRICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 178 AFRICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 179 AFRICA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 180 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 181 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 182 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 183 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 184 SOUTH AFRICA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 185 MOROCCO: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 186 MOROCCO: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 187 MOROCCO: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 188 MOROCCO: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 189 MOROCCO: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 190 REST OF AFRICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 191 REST OF AFRICA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 192 REST OF AFRICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 193 REST OF AFRICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 194 REST OF AFRICA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 195 AFRICA: BRACHYTHERAPY MARKET, BY COUNTRY, 2019–2032 (USD BILLION)
TABLE 196 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 197 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 198 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 199 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 200 SOUTH AMERICA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 201 BRAZIL: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 202 BRAZIL: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 203 BRAZIL: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 204 BRAZIL: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 205 BRAZIL: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 206 ARGENTINA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 207 ARGENTINA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 208 ARGENTINA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 209 ARGENTINA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 210 ARGENTINA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 211 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY PRODUCT, 2019–2032 (USD BILLION)
TABLE 212 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 213 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 214 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY INDICATION, 2019–2032 (USD BILLION)
TABLE 215 REST OF SOUTH AMERICA: BRACHYTHERAPY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 216 PUBLIC PLAYERS STOCK SUMMARY
TABLE 217 PRODUCT LAUNCH
TABLE 218 PRODUCT APPROVAL
TABLE 219 ACQUISITION
TABLE 220 ELEKTA: PRODUCTS OFFERED
TABLE 221 ELEKTA: KEY DEVELOPMENTS
TABLE 222 BEBIG MEDICAL GMBH: PRODUCTS OFFERED
TABLE 223 BEBIG MEDICAL GMBH: KEY DEVELOPMENTS
TABLE 224 THERAGENICS CORPORATION: PRODUCTS OFFERED
TABLE 225 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 226 SIEMENS HEALTHINEERS AG: KEY DEVELOPMENTS
TABLE 227 ECKERT & ZIEGLER: PRODUCT OFFERED
TABLE 228 ECKERT & ZIEGLER: KEY DEVELOPMENTS
TABLE 229 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 230 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 231 GE HEALTHCARE: KEY DEVELOPMENTS
TABLE 232 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
TABLE 233 MERIT MEDICAL SYSTEMS: KEY DEVELOPMENTS
TABLE 234 BEST MEDICAL INTERNATIONAL, INC.: PRODUCTS OFFERED
TABLE 235 BEST MEDICAL INTERNATIONAL, INC.: KEY DEVELOPMENTS
TABLE 236 ISOAID, LLC: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL BRACHYTHERAPY MARKET: STRUCTURE
FIGURE 2 GLOBAL BRACHYTHERAPY MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BRACHYTHERAPY MARKET
FIGURE 6 GLOBAL BRACHYTHERAPY MARKET, PRODUCT SEGMENT, 2023 & 2032
FIGURE 7 GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT, 2023 & 2032 (USD BILLION)
FIGURE 8 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY PRODUCT, 2023
FIGURE 9 GLOBAL BRACHYTHERAPY MARKET, TYPE SEGMENT, 2023 & 2032
FIGURE 10 GLOBAL BRACHYTHERAPY MARKET, BY TYPE, 2023 & 2032 (USD BILLION)
FIGURE 11 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY TYPE, 2023
FIGURE 12 GLOBAL BRACHYTHERAPY MARKET, TECHNIQUE SEGMENT, 2023 & 2032
FIGURE 13 GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2023 & 2032 (USD BILLION)
FIGURE 14 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY TECHNIQUE, 2023
FIGURE 15 GLOBAL BRACHYTHERAPY MARKET, INDICATION SEGMENT, 2023 & 2032
FIGURE 16 GLOBAL BRACHYTHERAPY MARKET, BY INDICATION, 2023 & 2032 (USD BILLION)
FIGURE 17 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY INDICATION, 2023
FIGURE 18 GLOBAL BRACHYTHERAPY MARKET, END USER SEGMENT, 2023 & 2032
FIGURE 19 GLOBAL BRACHYTHERAPY MARKET, BY END USER, 2023 & 2032 (USD BILLION)
FIGURE 20 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY END USER, 2023
FIGURE 21 GLOBAL BRACHYTHERAPY MARKET, BY REGION, 2023 & 2032 (USD BILLION)
FIGURE 22 GLOBAL BRACHYTHERAPY MARKET SHARE (%), BY REGION, 2023
FIGURE 23 NORTH AMERICA MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
FIGURE 24 NORTH AMERICA BRACHYTHERAPY MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 25 NORTH AMERICA BRACHYTHERAPY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 26 EUROPE MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
FIGURE 27 EUROPE BRACHYTHERAPY MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 28 EUROPE BRACHYTHERAPY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 29 ASIA-PACIFIC MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
FIGURE 30 ASIA-PACIFIC BRACHYTHERAPY MARKET, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 31 ASIA-PACIFIC BRACHYTHERAPY MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 32 REST OF THE WORLD MARKET ANALYSIS: BRACHYTHERAPY MARKET, 2019-2032 (USD BILLION)
FIGURE 33 REST OF THE WORLD: BRACHYTHERAPY MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD BILLION)
FIGURE 34 REST OF THE WORLD: BRACHYTHERAPY MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 35 GLOBAL BRACHYTHERAPY MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 36 COMPETITOR DASHBOARD: GLOBAL BRACHYTHERAPY MARKET
FIGURE 37 ELEKTA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 ELEKTA: SWOT ANALYSIS
FIGURE 39 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
FIGURE 41 ECKERT & ZIEGLER: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 ECKERT & ZIEGLER: SWOT ANALYSIS
FIGURE 43 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 45 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 47 MERIT MEDICAL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們